Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation (Q39561205)

13 September 2017

Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

Cristovao F Lima

2

0 references

Cristina Pereira-Wilson

object named as

Cristina Pereira-Wilson

series ordinal

4

0 references

author name string

Cristina P R Xavier

series ordinal

1

1 reference

PubMed ID

21479885

13 September 2017

Mikkel Rohde

series ordinal

3

1 reference

13 September 2017

11 April 2011

1 reference

Cancer Chemotherapy and Pharmacology

13 September 2017

1 reference

13 September 2017

68

1 reference

13 September 2017

6

1 reference

13 September 2017

1449-1457

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-011-1641-9

13 September 2017

0 references

cites work

Colon cancer: genomics and apoptotic events

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Resistance to 5-fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Colon cancer and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Microsatellite instability in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Clinical implications of microsatellite instability in sporadic colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Natural products and colon cancer: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Role of JNK activation in apoptosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

p38(MAPK): stress responses from molecular mechanisms to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Cell death in response to antimetabolites directed at thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

PI3K-Akt pathway: its functions and alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1641-9

10.1007/S00280-011-1641-9

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21479885